Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Gastroenterology · Hiatal Hernia

Daily Management and Medical Treatments

At a Glance

Hiatal hernia symptoms can often be managed with meal timing, head-of-bed elevation, weight loss when appropriate, and correctly timed proton pump inhibitors. These steps reduce reflux but do not repair the hernia; selected patients may qualify for TIF or cTIF after specialist evaluation.

Managing a hiatal hernia without surgery is a two-part strategy: physically keeping acid down through lifestyle changes and chemically suppressing it with medication. It is important to note that while PPIs and lifestyle changes reduce acid and help heal reflux injury, they do not physically move the stomach back into place, nor do they treat mechanical issues like an obstruction or a twisting stomach (volvulus). For many people with mild symptoms, these measures are enough to control reflux and prevent damage to the esophagus.

Targeted Lifestyle Adjustments

Lifestyle changes are most effective when they match your specific symptom patterns. Rather than following a generic list of “forbidden foods,” focus on the physical mechanics of your digestion [1].

  • Gravity is Your Ally: If you suffer from nighttime reflux, elevating the head of your bed is one of the most evidence-supported steps you can take. Using extra pillows can actually make symptoms worse by bending your body and increasing pressure on your stomach. Instead, use bed risers (blocks placed under the head of the bed frame) or a firm wedge pillow to create a 6-to-8-inch incline [2][3].
  • The Three-Hour Rule: Your stomach needs time to empty. Avoiding late-evening meals—leaving at least a 3-hour gap between your last bite and lying down—can significantly reduce nighttime acid exposure [1][3].
  • Strategic Weight Loss: If you are overweight or obese, even a modest weight reduction can lower the “intra-abdominal pressure” that pushes your stomach through the hiatus [2]. Studies show that weight loss is directly linked to a decrease in the time your esophagus is exposed to acid [1].
  • Identify Your Own Triggers: While coffee, chocolate, and spicy foods are famous triggers, they don’t affect everyone. Instead of a “blanket ban,” keep a diary to see which foods reproducibly cause your symptoms [4][5].

Optimizing Your Medications

Proton Pump Inhibitors (PPIs) are a primary medical treatment for managing acid reflux symptoms and healing esophagitis. However, they are often taken incorrectly, which can lead to “treatment failure” [6].

  • Timing is Everything: Most PPIs (like omeprazole or lansoprazole) must be taken on an empty stomach, ideally 30 to 60 minutes before breakfast [7]. This timing allows the medicine to enter your system just as your stomach’s “acid pumps” are most active [8]. If you take them with or after a meal, they may be far less effective.
  • Long-Term Use: For severe erosive disease (LA Grade C or D) or Barrett’s esophagus, long-term PPI maintenance therapy is often recommended to prevent complications like strictures [9][10].
  • Managing Risks: You may have heard concerns about long-term PPI use and kidney disease or bone density. Most of these links come from observational studies and do not prove the medication is the cause [11][12]. For patients with clear indications, the benefit of preventing esophageal damage commonly outweighs these uncertain risks, though your doctor should periodically review your need for the medication [13].
  • Deprescribing: If your symptoms have been well-controlled for months and you don’t have severe complications, your doctor may suggest “deprescribing”—slowly tapering your dose to see if you can manage with “on-demand” use [10][14]. Patients with severe erosive esophagitis, Barrett’s esophagus, peptic stricture, or a high risk of bleeding may not be appropriate candidates for dose reduction. Tapering should always be clinician-directed.

Endoscopic Options: TIF and cTIF

For patients with a small hiatal hernia (usually 2 centimeters or less) who want to avoid daily medication or major surgery, endoscopic options like Transoral Incisionless Fundoplication (TIF) may be an option [15][16].

In a TIF procedure, a doctor uses a device through an endoscope (down your throat) to fold the top of the stomach around the esophagus, recreating the “flap valve” without an external incision [17]. For slightly larger hernias (up to 5 centimeters), a newer approach called cTIF combines a small laparoscopic repair with the TIF procedure [18][19]. These procedures are generally intended for carefully selected patients with objectively confirmed GERD, appropriate anatomy, and typically no major mechanical paraesophageal anatomy or advanced mucosal disease. They are not standard options for all hernias, and availability varies by specialist [20].

Common questions in this guide

How should I take a PPI for hiatal hernia reflux?
Many common proton pump inhibitors, including omeprazole and lansoprazole, work best on an empty stomach 30 to 60 minutes before breakfast. Follow the instructions for your specific medicine because timing can differ between products.
Can lifestyle changes put a hiatal hernia back in place?
No. Lifestyle changes and acid-reducing medicines can lessen reflux and help protect the esophagus, but they do not move the stomach back through the opening or correct mechanical problems such as obstruction or twisting.
Can I reduce or stop my PPI if my symptoms improve?
A clinician may consider a gradual, supervised dose reduction after symptoms have been controlled for months if severe complications are not present. People with severe erosive esophagitis, Barrett’s esophagus, a peptic stricture, or a high risk of bleeding may not be good candidates for reducing treatment.
What helps prevent nighttime reflux from a hiatal hernia?
Raise the head of the bed by about 6 to 8 inches with bed risers or use a firm wedge pillow. Also leave at least three hours between your last meal and lying down, because extra pillows can bend the body and increase pressure on the stomach.
Can weight loss improve hiatal hernia reflux?
If you are overweight or obese, even modest weight loss may lower pressure inside the abdomen and reduce the time the esophagus is exposed to acid. Weight loss may improve reflux symptoms, but it does not itself repair the hernia.
Who may be eligible for TIF or cTIF for a hiatal hernia?
TIF is generally considered for carefully selected people with a small hiatal hernia, often 2 centimeters or less, and objectively confirmed reflux. cTIF combines a small laparoscopic repair with TIF and may be considered for hernias up to about 5 centimeters when the anatomy is suitable and there is no major paraesophageal anatomy or advanced esophageal lining disease.
Are long-term PPIs safe for people with hiatal hernias?
For people with a clear need, such as severe erosive disease or Barrett’s esophagus, continuing a PPI may provide more benefit than the uncertain risks reported in observational studies. A clinician should periodically review whether ongoing treatment is still needed and use the lowest appropriate regimen.

Get notified when new evidence is published on hiatus hernia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (20)
  1. 1

    Dietary factors involved in GERD management.

    Fox M, Gyawali CP

    Best practice & research. Clinical gastroenterology 2023; (62-63()):101826 doi:10.1016/j.bpg.2023.101826.

    PMID: 37094911
  2. 2

    Lifestyle Intervention in Gastroesophageal Reflux Disease.

    Ness-Jensen E, Hveem K, El-Serag H, Lagergren J

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2016; (14(2)):175-82.e1-3.

    PMID: 25956834
  3. 3

    Lifestyle intervention for gastroesophageal reflux disease: a national multicenter survey of lifestyle factor effects on gastroesophageal reflux disease in China.

    Yuan LZ, Yi P, Wang GS, et al.

    Therapeutic advances in gastroenterology 2019; (12()):1756284819877788 doi:10.1177/1756284819877788.

    PMID: 31598134
  4. 4

    Consensus statements and recommendations on the management of mild-to-moderate gastroesophageal reflux disease in the Southeast Asian region.

    Goh KL, Lee YY, Leelakusolvong S, et al.

    JGH open : an open access journal of gastroenterology and hepatology 2021; (5(8)):855-863 doi:10.1002/jgh3.12602.

    PMID: 34386592
  5. 5

    Differences in Dietary and Lifestyle Triggers between Non-Erosive Reflux Disease and Reflux Esophagitis-A Multicenter Cross-Sectional Survey in China.

    Chen Y, Sun X, Fan W, et al.

    Nutrients 2023; (15(15)) doi:10.3390/nu15153400.

    PMID: 37571337
  6. 6

    Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

    Iwakiri K, Kinoshita Y, Habu Y, et al.

    Journal of gastroenterology 2016; (51(8)):751-67 doi:10.1007/s00535-016-1227-8.

    PMID: 27325300
  7. 7

    Therapy for peptic ulcer disease.

    Lukáš M

    Vnitrni lekarstvi 2018; (64(6)):595-599.

    PMID: 30223656
  8. 8

    25 Years of Proton Pump Inhibitors: A Comprehensive Review.

    Strand DS, Kim D, Peura DA

    Gut and liver 2017; (11(1)):27-37 doi:10.5009/gnl15502.

    PMID: 27840364
  9. 9

    The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.

    Freedberg DE, Kim LS, Yang YX

    Gastroenterology 2017; (152(4)):706-715 doi:10.1053/j.gastro.2017.01.031.

    PMID: 28257716
  10. 10

    AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.

    Targownik LE, Fisher DA, Saini SD

    Gastroenterology 2022; (162(4)):1334-1342 doi:10.1053/j.gastro.2021.12.247.

    PMID: 35183361
  11. 11

    Complications of Proton Pump Inhibitor Therapy.

    Vaezi MF, Yang YX, Howden CW

    Gastroenterology 2017; (153(1)):35-48 doi:10.1053/j.gastro.2017.04.047.

    PMID: 28528705
  12. 12

    Cardiovascular and non-cardiovascular concerns with proton pump inhibitors: Are they safe?

    Corsonello A, Lattanzio F

    Trends in cardiovascular medicine 2019; (29(6)):353-360 doi:10.1016/j.tcm.2018.10.008.

    PMID: 30389278
  13. 13

    Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies.

    Attwood SE, Ell C, Galmiche JP, et al.

    Alimentary pharmacology & therapeutics 2015; (41(11)):1162-74 doi:10.1111/apt.13194.

    PMID: 25858519
  14. 14

    Proton Pump Inhibitors: Rational Use and Use-Reduction - The Windsor Workshop.

    Kahrilas P, Anastasiou F, Bredenoord AJ, et al.

    Digestive diseases (Basel, Switzerland) 2024; (42(3)):211-220 doi:10.1159/000538399.

    PMID: 38513623
  15. 15

    Novel Interdisciplinary Approach to GERD: Concomitant Laparoscopic Hiatal Hernia Repair with Transoral Incisionless Fundoplication.

    Choi AY, Roccato MK, Samarasena JB, et al.

    Journal of the American College of Surgeons 2021; (232(3)):309-318 doi:10.1016/j.jamcollsurg.2020.11.021.

    PMID: 33346082
  16. 16

    The status of endoscopic therapies for gastroesophageal reflux disease.

    Kolb JM, Chang KJ

    Current opinion in gastroenterology 2023; (39(4)):326-332 doi:10.1097/MOG.0000000000000944.

    PMID: 37265186
  17. 17

    American Society for Gastrointestinal Endoscopy guideline on the diagnosis and management of GERD: methodology and review of evidence.

    , Desai M, Ruan W, et al.

    VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy 2025; (10(2)):81-137 doi:10.1016/j.vgie.2024.10.001.

    PMID: 40012897
  18. 18

    Short-Term Outcomes of Laparoscopic Hiatal Hernia Repair with Consecutive Transoral Incisionless Fundoplication: A Prospective Multicenter Cohort Study.

    Kolb JM, Canto MI, Parker B, et al.

    Journal of the American College of Surgeons 2026; (243(5)):1220-1229 doi:10.1097/XCS.0000000000002059.

    PMID: 42233490
  19. 19

    Concomitant hiatal hernia repair with transoral incisionless fundoplication for the treatment of refractory gastroesophageal reflux disease: a systematic review.

    Jaber F, Ayyad M, Ayoub F, et al.

    Surgical endoscopy 2024; (38(10)):5528-5540 doi:10.1007/s00464-024-11201-2.

    PMID: 39271515
  20. 20

    Outcomes of transoral incisionless fundoplication (TIF 2.0): a prospective multicenter cohort study in academic and community gastroenterology and surgery practices (with video).

    Canto MI, Diehl DL, Parker B, et al.

    Gastrointestinal endoscopy 2025; (101(1)):90-102.e1 doi:10.1016/j.gie.2024.08.016.

    PMID: 39293690

This page is for informational purposes only and does not constitute medical advice. Your gastroenterologist or surgeon should guide medication changes and determine whether an endoscopic procedure is appropriate for you.